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ABSTRACT The transporter ATP7A mediates systemic copper absorption and provides cu-
proenzymes in the trans-Golgi network (TGN) with copper. To regulate metal homeostasis, 
ATP7A constitutively cycles between the TGN and plasma membrane (PM). ATP7A trafficking 
to the PM is elevated in response to increased copper load and is reversed when copper 
concentrations are lowered. Molecular mechanisms underlying this trafficking are poorly un-
derstood. We assess the role of clathrin, adaptor complexes, lipid rafts, and Rab22a in an 
attempt to decipher the regulatory proteins involved in ATP7A cycling. While RNA interfer-
ence (RNAi)–mediated depletion of caveolin 1/2 or flotillin had no effect on ATP7A localiza-
tion, clathrin heavy chain depletion or expression of AP180 dominant-negative mutant not 
only disrupted clathrin-regulated pathways, but also blocked PM-to-TGN internalization of 
ATP7A. Depletion of the μ subunits of either adaptor protein-2 (AP-2) or AP-1 using RNAi 
further provides evidence that both clathrin adaptors are important for trafficking of ATP7A 
from the PM to the TGN. Expression of the GTP-locked Rab22aQ64L mutant caused fragmen-
tation of TGN membrane domains enriched for ATP7A. These appear to be a subdomain of 
the mammalian TGN, showing only partial overlap with the TGN marker golgin-97. Of impor-
tance, ATP7A remained in the Rab22aQ64L-generated structures after copper treatment and 
washout, suggesting that forward trafficking out of this compartment was blocked. This study 
provides evidence that multiple membrane-associated factors, including clathrin, AP-2, AP-1, 
and Rab22, are regulators of ATP7A trafficking.
INTRODUCTION
Copper is an essential trace element and an important cofactor 
for many enzymes with roles in neuronal function, embryonic de-
velopment, pigmentation, and other processes (Uauy et al., 1998; 
Pena et al., 1999; Harris, 2000; Balamurugan and Schaffner, 2006; 
Schlief and Gitlin, 2006). As a redox-active metal, excess copper 
is toxic to cells due to the risk of generating damaging free radi-
cals. Therefore tight regulation of copper balance is vital. Among 
the proteins known to be important in copper homeostasis is the 
copper-transporting ATPase ATP7A (Menkes protein, MNK), a 
member of the P-type ATPase family responsible for ATP-driven 
ion transport across membranes (Kuhlbrandt, 2004). ATP7A is 
ubiquitously expressed in the body, observed in the brain and 
several other tissues, such as kidney, lung, placenta, and mam-
mary gland (Lutsenko et al., 2007), but not liver, which shows high 
expression of ATP7B. Defects in copper transport are linked to 
human disease, and mutations in the ATP7A gene are responsible 
for Menkes disease, occipital horn syndrome (Tümer, 2013), and 
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PM to the TGN. We also show that ATP7A does not require clathrin 
for the constitutive delivery on the outbound pathway from the TGN 
to the PM. However, this route appears to involve the GTPase 
Rab22, as expression of a constitutively active mutant of Rab22a 
prevents ATP7A trafficking to the PM in response to copper. Thus 
our findings implicate clathrin, AP-2, AP-1, and Rab22 as novel reg-
ulators of ATP7A trafficking and copper homeostasis.
RESULTS
ATP7A trafficking requires clathrin but not caveolin 
or flotillin
Multiple pathways operate to traffic membrane and soluble cargoes 
to and from the cell surface (Hansen and Nichols, 2009). To test 
whether clathrin- or lipid raft–mediated regulation was involved in 
ATP7A internalization, we depleted specific regulatory proteins us-
ing RNA interference (RNAi). We targeted the caveolin-, flotillin-, 
and clathrin-regulated steps in HeLa cells using small interfering 
RNA (siRNA) duplexes directed against caveolin 1 (cav1), caveolin 2 
(cav2), flotillin 1 (flot1), or clathrin heavy chain (CLTC). The efficiency 
of protein depletion (knockdown) was confirmed by immunoblot-
ting (Figure 1A). Note that the siRNA against cav1 causes a decrease 
in both cav1 and cav2 levels. This was reported previously (Bhatnagar 
et al., 2004) and is believed to be due to cav1 being required to 
stabilize cav2 (Razani et al., 2001).
Using immunofluorescence (IF) and confocal microscopy we 
analyzed the localization of ATP7A in cells transfected with control 
or target siRNA (Figure 1B). In controls, under copper-limiting con-
ditions after incubation with the copper chelator bathocuproine-
disulfonic acid (BCS), ATP7A is observed predominantly in a peri-
nuclear location (Figure 1B, a). This is consistent with reports of its 
basal presence in the TGN (Yamaguchi et al., 1996). Similarly, in 
cells subjected to knockdown for cav1, cav2, or flot1 (Figure 1B, 
b–d), ATP7A still resides predominantly in the TGN. However, 
when cells are transfected with siRNA against clathrin heavy chain, 
a large proportion of ATP7A is mislocalized to the cell surface 
(Figure 1B, e).
Although ATP7A shows predominant TGN localization under 
steady-state conditions, exposing cells to high levels of copper in-
duces ATP7A to traffic out of the TGN to the cell surface (Petris 
et al., 1996; Cobbold et al., 2002). This relocalization is reversible 
upon copper washout, and ATP7A returns to the TGN. In cells sub-
jected to cav1, cav2, or flot1 knockdown ATP7A moved to the cell 
surface when cells were incubated with excess copper ions (Figure 
1B, g–i) and returned to the TGN after copper washout (Figure 1B, 
l–n), similar to control cells (Figure 1B, f and k). In contrast, in cells 
depleted of clathrin, ATP7A relocated to the PM in the presence of 
elevated copper (Figure 1B, j) but remained mislocalized to cell sur-
face after copper washout (Figure 1B, o).
To confirm that mislocalization of ATP7A was a result of reduced 
clathrin levels, we colabeled clathrin-depleted cells with antibodies 
against clathrin heavy chain and ATP7A (Supplemental Figure S1A, 
b and d). Surface accumulation of fluorescence-labeled transferrin 
(Tf) confirms that CME is blocked in these cells (Supplemental Figure 
S1A, f). The results demonstrate that where Tf internalization is 
blocked by depletion of clathrin, ATP7A is mislocalized to the cell 
surface region (Supplemental Figure S1A, b, d, f, and h). This ATP7A 
cell surface pattern is similar in both BCS- and copper-treated cells 
(Supplemental Figure S1B, compare d and e), and after copper 
washout, ATP7A was unable to return to the TGN (Supplemental 
Figure S1B, f and i).
We further quantified ATP7A (and Tf) internalization in clathrin-
depleted cells by assessing the mean area of ATP7A (or Tf) 
The ATP7A transporter meets the challenge of fluctuating cop-
per levels by relocating to sites where copper transport is needed, 
and this trafficking seems to be crucial for the export of copper from 
the cell. At low basal levels of copper, ATP7A resides predominantly 
in the trans-Golgi network (TGN), with a small amount constitutively 
cycling between the TGN and the plasma membrane (PM; Petris 
et al., 1996). This location is compatible with ATP7A’s role of pump-
ing copper into the TGN lumen to supply cuproenzymes traversing 
the secretory pathway. When copper levels are raised, a majority of 
ATP7A relocates to the plasma membrane, or in some cell types to 
vesicles close to the plasma membrane, to export excess copper 
from the cell, returning to the TGN when copper levels are reduced 
(Petris et al., 1996; Nyasae et al., 2007). Further evidence suggests 
that increasing copper levels shifts ATP7A into a rapid recycling 
pool, preventing its return to the TGN and maintaining the trans-
porter in the vicinity of the PM (Pase et al., 2003).
Specific motifs within proteins are essential for linking them to 
the trafficking machinery. Trafficking signals in the carboxyl-terminal 
cytosolic domain of ATP7A include a dileucine motif (LL positions 
1487–1488), required for the internalization of ATP7A from the cell 
surface (Petris et al., 1998; Petris and Mercer, 1999; Francis et al., 
1999); a class 1 PDZ target motif (DTAL positions 1497–1500), 
important for basolateral membrane targeting (Greenough et al., 
2004); and phosphorylation of serine residues, required for traffick-
ing to the PM (Veldhuis et al., 2009). The N-terminal copper-binding 
domains are also crucial, as it is clear that one of the six copper-
binding domains is needed for trafficking to the PM (Goodyer et al., 
1999; Strausak et al., 1999; Mercer et al., 2003). It is likely that a 
conformational shift triggered by copper binding exposes the tar-
get information within ATP7A to enable traffic. It was also proposed 
that glutathionylation and deglutathionylation of ATP7A might play 
a role in the transporter’s trafficking (Singleton et al., 2010).
The importance of the dileucine motif for ATP7A internalization 
suggests a clathrin-mediated pathway for endocytosis, although at-
tempts to block this pathway do not prevent ATP7A from internal-
izing (Cobbold et al., 2003; Lane et al., 2004). Clathrin is recruited to 
the membrane through interactions with the lipid-binding protein 
AP180 (Ford et al., 2001). Selection of cargo into clathrin-coated 
structures is mediated through recruitment by transient adaptors. 
Among the best characterized are the heterotetrameric adaptor 
proteins (APs) AP-1 and AP-2, consisting of μ1, β1, σ1, and γ for 
AP-1 and μ2, β2, σ2, and α for AP-2. Adaptors recognize signals in 
the cytoplasmic portion of membrane proteins that contain dileu-
cine or tyrosine residues (Traub, 2009). Despite their similarity, AP-2 
is associated with sorting cargo for clathrin-mediated endocytosis 
(CME) from the PM, whereas AP-1 is associated with sorting of car-
goes shuttling between endosomes and the TGN (Robinson, 
2004).
Additional regulatory components organize cargo transport be-
tween different compartments in the cell. Ras-related proteins in 
brain (Rabs) are GTPases that coordinate the complex processes of 
vesicular/tubular carrier formation, motility, tethering, and fusion. 
These small proteins function as molecular switches by cycling be-
tween a GTP-bound, active and a GDP-bound, inactive state, and a 
number of Rabs are involved in post-Golgi and endosomal traffick-
ing (Zerial and McBride, 2001; Schwartz et al., 2007; Stenmark, 
2009).
In this study we explore the trafficking mechanisms used by 
ATP7A to cycle within HeLa cells. We show that inhibition of clathrin-
regulated pathways prevents ATP7A from being internalized at the 
PM before delivery to the TGN. Recruitment of ATP7A into the CME 
pathway appears to involve both AP-2 and AP-1 en route from the 
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was not an issue, we stained clathrin-depleted cells with the 
cis-Golgi marker GM130 or the TGN marker P230. Depleted cells 
were identified using cell surface accumulation of labeled Tf. Cells 
depleted of clathrin show normal Golgi and TGN architecture 
(Figure 2B). Thus clathrin depletion does not cause collapse of the 
Golgi/TGN, but it affects the trafficking of ATP7A as it moves be-
tween the cell surface and the TGN. The loss of ATP7A staining in 
the TGN of clathrin-depleted cells was not due to degradation 
because analogous levels of ATP7A were present in clathrin-de-
pleted and nondepleted cells (Figure 2A). Despite >85% reduction 
in clathrin heavy chain levels in depleted cells, the levels of ATP7A 
were unaffected.
fluorescence labeling on a cell-by-cell basis (Supplemental Figure 
S2). In this assay inhibition of internalization will result in an in-
creased fluorescence area as ATP7A (or Tf) is redistributed 
throughout the cell. The analysis was performed on 12 randomly 
imaged fields of view in triplicate, representing a sample of 3000–
4000 cells per condition. Indeed, clathrin depletion results in a 
significant increase in the mean area of ATP7A fluorescence com-
pared with ATP7A distribution in nontargeting siRNA controls. 
This result is similar to that observed for Tf, reconfirming that 
clathrin depletion results in an ATP7A-trafficking block.
Depletion of clathrin may affect the integrity of the TGN, caus-
ing ATP7A mislocalization. To verify that Golgi and TGN collapse 
FIGURE 1: Clathrin is required for ATP7A trafficking. HeLa cells were treated with transfection reagent alone (mock), 
transfected with nonsilencing siRNA (-ve) or siRNA directed against cav1, cav2, flot1, or CLTC. (A) Immunoblot shows 
depletion of target proteins (indicated above the blot). A total of 10 μg of total protein was loaded per lane. Proteins 
are detected with the antibodies indicated on the left. (B) Cells were treated with BCS (a–e), CuCl2 (f–j), or CuCl2 
followed by washout (k–o) at 37°C before fixation and IF staining with anti-ATP7A antibody (green) and DAPI nuclear 
stain (blue). Scale bar, 10 μm; where scale bar is not shown, scale is equivalent to that of n.
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ATP7A accumulates at the cell surface 
in clathrin-depleted cells
Our data suggest that ATP7A accumulates 
at the surface in cells depleted of clathrin. 
To verify this, we performed a cell surface 
biotinylation assay comparing surface levels 
of ATP7A in control and clathrin-depleted 
cells.
After siRNA treatment, cells were incu-
bated with either BCS, to deplete copper in 
the culture media, or elevated copper, to 
stimulate trafficking of ATP7A to the cell sur-
face. We then biotinylated the cell surface at 
4°C, lysed the cells, and isolated the biotiny-
lated cell surface proteins on NeutrAvidin 
beads. We analyzed the samples by SDS–
PAGE and immunoblotting with anti-ATP7A 
antibodies. Figure 3 shows that in control 
cells treated with BCS, ATP7A was present 
at low levels on the cell surface (6.7 ± 3.9%), 
and this level was greatly increased when 
cells were incubated with copper (59.7 ± 
6.7%). In contrast, in clathrin-depleted cells 
the amount of ATP7A at the cell surface is 
high for both BCS-treated (52.2 ± 1.7%) and 
copper-treated cells (54.1 ± 13.8% of total). 
Samples were also probed for actin as a 
negative control to demonstrate specificity 
for cell surface protein isolation (Figure 3A). 
Thus the cell surface biotinylation experi-
ments show a significant relocation of ATP7A 
to the cell surface in clathrin-depleted cells, 
independent of copper. Of importance, this 
demonstrates that exocytic traffic of ATP7A 
from the TGN to the cell surface occurs in 
clathrin-depleted cells and therefore does 
not rely on clathrin.
Internalization of ATP7A from the cell 
surface is dependent on clathrin 
adaptors AP180 and AP-2
We further investigated the role of clath-
rin in ATP7A internalization by inhibiting 
the recruitment of clathrin to membranes 
through the expression of a dominant-
negative fragment of the tethering pro-
tein AP180. Overexpression of the car-
boxyl-terminus of AP180 (AP180-C), which 
lacks the lipid-binding domain, leads to 
the inhibition of both epidermal growth 
factor and Tf internalization, thus confirm-
ing its effect as a potent inhibitor of the 
CME pathway (Ford et al., 2001). We ex-
pressed AP180-C in HeLa cells and treated 
them with BCS, elevated copper, or ele-
vated copper followed by washout. In 
BCS-treated cells, expression of AP180-C 
causes the redistribution of ATP7A to the 
PM (Figure 4, d and g), similar to that seen 
in copper-treated cells (Figure 4, e and h). 
When copper is washed out, ATP7A does 
not return to the TGN in cells expressing 
FIGURE 2: Clathrin depletion does not affect ATP7A levels or Golgi/TGN architecture. 
(A) Lysates of siRNA-treated cells containing 10 μg of total protein per lane were separated by 
SDS–PAGE, followed by immunoblotting with the antibodies indicated on the left of the blot. 
ATP7A protein levels were quantified, normalized against actin levels, and expressed as 
percentage of mock control. The graph is representative of six independent experiments. 
(B) The integrity of the Golgi and the TGN were verified in CLTC-depleted cells by labeling with 
the cis-Golgi marker GM130 or the TGN marker P230 (green). Cells were incubated with Alexa 
Fluor 594-Tf (red) at 37°C before washing and fixation to identify clathrin-depleted cells. Scale 
bar, 10 μm.
FIGURE 3: Depletion of clathrin causes ATP7A to accumulate at the cell surface. CLTC-
deleted or control HeLa cells transfected with nonsilencing siRNA (-ve) were treated with 
BCS or CuCl2. Cell surface proteins were labeled with biotin at 4°C, followed by cell lysis 
and isolation of biotinylated cell surface proteins on NeutrAvidin beads. (A) Western blot 
of prebead lysate (ly) or eluted cell surface e1 protein samples (cs) probed with an 
antibody to ATP7A or actin. (B) Quantification of cell surface ATP7A, calculated as a 
percentage of total ATP7A in the cell lysate. The graph is representative of three 
independent experiments.
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system, a well-characterized method to 
study sorting signals in the carboxyl termini 
of transmembrane proteins (Nilsson et al., 
1989; Kozik et al., 2010). We previously 
showed that substituting the CD8 cytoplas-
mic domain for the extreme carboxyl-termi-
nal 24 amino acids of ATP7A containing 
the DKHSLL motif (residues 1477–1500, 
VVTSEPDKHSLLVGDFREDDDTAL*; result-
ing construct CD8-LL4) triggers the internal-
ization of the normally cell surface located 
CD8 (Francis et al., 1999).
Control cells treated with nontargeting 
siRNA or cells depleted of clathrin heavy 
chain or AP-2 were transiently transfected 
with the CD8-LL4 construct and allowed to 
internalize OKT8, an antibody against the 
CD8 extracellular domain (Supplemental 
Figure S3A, a–c), together with labeled Tf 
(Supplemental Figure S3A, d–f) before fixa-
tion. Cells depleted of clathrin or AP-2 were 
identified by accumulation of labeled Tf at 
the cell surface. Further confirmation of 
clathrin depletion was done by staining 
with an antibody against clathrin heavy 
chain (Supplemental Figure S3A, j and k). In 
depleted cells, CD8-LL4 was prevented 
from internalizing compared with the con-
trol, which internalized both OKT8 and Tf 
(Supplemental Figure S3A).
Using the approach described for Sup-
plemental Figure S2, we quantified OKT8 
internalization in CD8-LL4–expressing cells 
depleted of clathrin or AP-2 or controls 
treated with nontargeting siRNA (Supple-
mental Figure S3B). From binary images we 
assessed the mean area of OKT8 (or Tf) fluo-
rescence labeling on a cell-by-cell basis, 
with inhibition of internalization resulting in increased fluorescence 
area as OKT8 (or Tf) is redistributed throughout the cell. The quan-
tification results confirm that CD8-LL4 internalization is significantly 
reduced in clathrin- or AP-2–depleted cells. Therefore the extreme 
C-terminus containing the DKHSLL motif is likely to be responsible 
for linking ATP7A to the AP-2 and clathrin machinery.
AP-1 is required for the TGN localization of ATP7A
AP-1 clathrin adaptor has also been shown to bind to [D/E]XXXL[L/I] 
motifs. AP-1 functions at the TGN and within the endosomal path-
way (Bonifacino and Traub, 2003) and is involved in the recycling of 
M6PR to the TGN (Meyer et al., 2000). To test its putative role in the 
trafficking of ATP7A, we reduced the expression of the AP-1 com-
plex by silencing its μ1A subunit. We were unable to obtain a suit-
able antibody to check the depletion of μ1A. However, because the 
γ adaptin subunit of AP-1 becomes cytosolic when μ1A is knocked 
down, we could identify depleted cells by diffuse rather than mem-
brane-associated immunofluorescence of γ adaptin (Figure 6A, a–c; 
Meyer et al., 2000; Hirst et al., 2003, 2004; Byland et al., 2007). We 
also confirmed by Western blot that the depletion of μ1A does not 
affect the levels of the μ2 subunit of AP-2 (Figure 6C).
In AP-1–depleted cells treated with BCS, ATP7A staining is dis-
persed, in contrast to the TGN localization observed in nonde-
pleted cells (compare Figure 6A, d and g). Copper treatment causes 
the AP180-C protein (Figure 4, f and i), in contrast to nontrans-
fected cells.
ATP7A contains a dileucine carboxyl-terminal sequence within 
the motif DKHSLL, implicated in the internalization of the trans-
porter (Petris et al., 1998; Petris and Mercer, 1999; Francis et al., 
1999). Sequences fitting [D/E]XXXL[L/I] motifs bind the clathrin 
adaptor AP-2, mainly through interactions with the σ2 subunit and 
contributions from the α subunit (Kelly et al., 2008). The depletion 
of the μ2 subunit of AP-2 by RNAi inhibits AP-2–mediated endocy-
tosis (Fraile-Ramos et al., 2003; Motley et al., 2003), and we used 
this method to probe the role of the AP-2 pathway in ATP7A 
trafficking.
AP-2 μ2 subunit was efficiently depleted in HeLa cells (Figure 
5A). In AP-2–depleted cells under BCS conditions, ATP7A was ob-
served at the TGN (Figure 5B, d and g) and relocated to the cell 
surface when cells were treated with copper (Figure 5B, e and h). 
However, after copper washout, ATP7A fails to return to the TGN, as 
observed in the nondepleted cells (Figure 5B, f and i). These data 
further support that clathrin and the clathrin adaptors AP180 and 
AP-2 are essential for ATP7A traffic between the PM and the TGN. 
However, they do not appear essential for the movement of ATP7A 
from the TGN to the PM.
To confirm the involvement of the carboxyl-terminus in targeting 
ATP7A to the clathrin machinery, we used a CD8 chimera reporter 
FIGURE 4: ATP7A internalization is inhibited in cells expressing AP180-C. Transiently transected 
HeLa cells expressing myc-tagged AP180-C were subjected to treatment with BCS, CuCl2, or 
CuCl2, followed by washout. AP180-C is detected with an antibody against the myc epitope 
(a–c, g–i red), and cells are counterstained for ATP7A (d–f, g–i green). Scale bar, 10 μm.
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(Supplemental Figure S4d). Our data suggest that ATP7A does not 
use the Rab11-regulated recycling pathway.
Rab22a has been proposed to regulate the recycling pathway 
from early endosomes to the PM (Weigert and Donaldson, 2005; 
Magadan et al., 2006; Barral et al., 2008). In addition, its close ho-
mologue Rab22b has been shown to facilitate the traffic between 
the TGN and the sorting endosome (Rodriguez-Gabin et al., 2001, 
2009). To assess the role of Rab22a in ATP7A trafficking, we ex-
pressed the dominant-negative Rab22aS19N and constitutively ac-
tive Rab22aQ64L mutants in cells.
Figure 7 shows experiments performed in cells treated with BCS 
. In cells expressing the dominant-negative Rab22aS19N mutant, 
ATP7A localized to the TGN in a pattern analogous to that observed 
in untransfected cells (Figure 7a). In contrast, in cells expressing the 
constitutively active Rab22aQ64L mutant, ATP7A was detected in a 
dispersed punctate pattern (Figure 7, b–f). The nature of the dis-
persed ATP7A-containing compartment was probed by colabeling 
the ATP7A puncta with markers for the cis-Golgi, TGN, and endo-
somal compartments. In Rab22aQ64L-expressing cells, the cis-Golgi 
marker GM130 also appeared dispersed, but did not colocalize with 
ATP7A (Figure 7c, inset in merge). The Tf receptor localization ap-
peared unaltered, and Tf receptor did not colocalize with the ATP7A 
puncta (Figure 7d, inset in merge). The ATP7A-containing compart-
ment was distinct from early endosomes, as shown by lack of colo-
calization with early endosome antigen 1 (EEA1; Figure 7e, inset in 
merge). However, this compartment may be at least partly made up 
of dispersed TGN, as indicated by a partial overlap of ATP7A and 
golgin-97 staining (Figure 7f, inset in merge). This effect of 
Rab22aQ64L expression on the TGN was not previously described.
relocation of ATP7A to the cell surface, showing a similar pheno-
type to nondepleted cells (Figure 6A, e and h). However, upon cop-
per washout, ATP7A again shows diffuse staining, similar to the 
BCS-treated cells (Figure 6A, f and i).
We were concerned that AP-1 depletion might compromise the 
integrity of the TGN and account for the dispersed ATP7A pheno-
type. To demonstrate that Golgi and TGN architecture is unaffected 
by the loss of AP-1, we stained depleted cells for the markers GM130 
and golgin-97. Normal staining pattern for GM130 and golgin-97 
was observed in control and AP-1–depleted cells (Figure 6B), sug-
gesting that the dispersed ATP7A localization was a result of a traf-
ficking block and not the collapse of the TGN.
ATP7A localization and trafficking are regulated by Rab22
Rab-mediated sorting events occur at the level of endosomes and 
the TGN. We assessed pathways mediating ATP7A trafficking by 
transiently expressing Rab constructs locked in either their GDP 
(dominant negative) or GTP (constitutively active) forms. Rab11 
and Rab22 are implicated in the regulation of protein recycling 
and traffic to the TGN (for review see Schwartz et al., 2007; 
Stenmark, 2009). We first assessed the role of Rab11 in ATP7A traf-
ficking. In cells under low copper conditions, expression of domi-
nant-negative forms of Rab11a and b (S25N) had no effect on 
ATP7A localization to the TGN (Supplemental Figure S4, a and b). 
In addition, expression of the constitutively active form of Rab11b 
(Q70L) did not affect ATP7A localization to the TGN under low-
copper conditions (Supplemental Figure S4c). When overex-
pressed, Rab11bQ70L localizes to puncta in some cells; after cop-
per treatment, ATP7A did not enter the Rab11-positive structures 
FIGURE 5: Internalization of ATP7A is inhibited in cells depleted of AP-2. (A) Immunoblot comparing lysates from cells 
treated with nontargeting siRNA (-ve) or depleted of CLTC or AP-2 using siRNA against μ2 subunit of the AP-2 complex. 
A total of 10 μg of total protein was loaded per lane. Membranes were probed with the antibodies indicated on the left 
of the blot. (B) HeLa cells depleted of AP-2 were treated with BCS, CuCl2, or CuCl2, followed by washout. Cells showing 
knockdown of AP-2 are identified by accumulation of Alexa Fluor 594–Tf (a–c, g–i red) at the cell surface, and examples in 
the merge panels are marked by asterisk. Cells are counterstained for ATP7A (d–f, g–i green). Nondepleted cells showing 
transferrin internalization are used as an internal negative control; examples are marked with an arrow. Scale bar, 10 μm.
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When Rab22aQ64L-expressing cells were treated with copper, 
ATP7A remained in puncta and did not relocate to the cell surface 
(Figure 8a). The punctate structures did not colocalize with EEA1 
(Figure 8b) and appeared mostly independent of golgin-97 (Figure 
8c), suggesting that they might be a subcompartment of the TGN 
separate from golgin-97 TGN elements. ATP7A remained in a punc-
tate pattern after copper washout (Figure 8d). Taken together, our 
data suggest that constitutively active Rab22aQ64L arrests ATP7A 
within a TGN compartment and prevents movement to the PM dur-
ing copper stimulation.
DISCUSSION
It is well established that ATP7A traffics between the TGN and the 
PM and/or sub-PM vesicles in response to changing intracellular 
copper levels (Petris et al., 1996; Nyasae et al., 2007). However, our 
understanding of how ATP7A recycling is regulated and the factors 
involved are not well understood.
Clathrin regulates the internalization of ATP7A 
from the cell surface
Previous studies showed that structural features in ATP7A are impor-
tant for the copper transporter to internalize. Mutating a dileucine 
motif in the extreme carboxyl-terminus inhibits ATP7A internaliza-
tion and strongly points toward the involvement of clathrin in ATP7A 
endocytosis (Francis et al., 1999; Petris and Mercer, 1999). Recently 
it was reported that the distal motor neuropathy causing mutation, 
P1386S, in TM domain 8 of ATP7A causes relocation of the C-termi-
nus to the extracellular surface and accumulation of ATP7A at the 
PM (Yi et al., 2012). Furthermore, blocking CME by subjecting cells 
to hypertonic conditions (Pase et al., 2003; Lane et al., 2004) also 
prevents ATP7A internalization.
For the first time we directly assessed clathrin’s involvement in 
ATP7A trafficking by depleting clathrin heavy chain levels using 
RNAi. Here we show that ATP7A becomes trapped at the cell sur-
face when clathrin is knocked down or clathrin recruitment to the 
membrane is blocked by the overexpression of the AP180 carboxyl-
terminus. Our results demonstrate a direct involvement of clathrin in 
ATP7A endocytic trafficking but, of interest, not in exocytosis of 
ATP7A from the TGN.
Despite these findings, other experimental approaches seem to 
indicate otherwise. Earlier studies by our lab and others (Cobbold 
et al., 2003; Lane et al., 2004) showed that dominant-negative mu-
tants of dynamin (the large GTPase proposed to facilitate scission of 
clathrin-coated vesicles; Marks et al., 2001), which block CME (van 
der Bliek et al., 1993; Damke et al., 1994; Altschuler et al., 1998), 
do not inhibit the copper-regulated internalization of ATP7A 
FIGURE 6: AP-1 depletion blocks ATP7A trafficking to the TGN. (A) HeLa Cells depleted of AP-1 by transfection with 
siRNA targeting the μ1 subunit were treated with BCS, CuCl2, or CuCl2, followed by washout. Cells depleted of AP-1 
are identified by loss of adaptin γ signal at the TGN (a–c, g–i red). Cells are counterstained for ATP7A (d–f, g–i green). 
Examples of depleted cells are marked in the merge panels with asterisk, and nondepleted cells are marked with an 
arrow. (B) AP-1–depleted cells, identified by loss of adaptin γ signal (red), are labeled for the trans-Golgi marker 
golgin-97 (green) or the cis-Golgi marker GM130 (blue). Scale bar, 10 μm. (C) Immunoblot of lysates from control cells 
(-ve) or those depleted of AP-1 or AP-2 and blotted with antibodies indicated on the left of the blot. A total of 10 μg of 
protein was loaded per lane.
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FIGURE 7: Expression of the constitutively active mutant Rab22aQ64L fragments the TGN. HeLa cells transiently 
transfected with myc-tagged, dominant-negative Rab22aS19N (a) or the constitutively active Rab22aQ64L (b–f) were 
treated with BCS, fixed, and colabeled with an antibody against myc to detect the Rab22a mutants (a–f red) or with 
antibodies for the indicated markers (c–f pink). Cells are counterstained for ATP7A (a–f green). DAPI staining (blue) 
labels the nucleus. ATP7A appears in puncta in Rab22aQ64L-expressing cells. In merge, inset of f, the arrow indicates 
puncta showing no colocalization between ATP7A and golgin-97 in Rab22aQ64L-expressing cells, and the arrowhead 
indicates areas of colocalization. Scale bar, 10 μm.
(we reconfirmed these results for the present study, observing no 
effect of overexpression of dynamin 1 and 2 K44A mutants on 
ATP7A trafficking; Supplemental Figure S5). On further investigation 
we found that treating HeLa cells with the dynamin-inhibiting drug 
Dynasore during copper washout traps ATP7A at the plasma mem-
brane (Supplemental Figure S6). These results suggest that a form 
of dynamin might be involved in the internalization of ATP7A and 
support a role for CME. According to the currently accepted, most 
common clathrin-mediated endocytosis model of PM proteins, 
these data appear contradictory. However, other reports indicate 
there are reasons that may explain them. Dynasore affects a number 
of dynamin isoforms, disabling not only dynamin 1, dynamin 2, and 
Drp1, the mitochondrial dynamin (Macia et al., 2006), but also po-
tentially dynamin 3 (Lou et al., 2012). It is also possible that Dynas-
ore is targeting another unidentified GTPase required at the early 
stages of invagination (Nankoe and Sever, 2006). This broad-range 
block of dynamin activity is sufficient to impair internalization of 
ATP7A from the PM, whereas blocking only either dynamin 1 or 
dynamin 2 is not. Identification of the specific target of Dynasore 
involved in ATP7A internalization via CME will need further investi-
gation. In any case, the lack of effect of K44A mutants cannot be 
taken as full proof of clathrin-independent internalization.
There are other cases reported in which internalization is clathrin 
dependent but is not blocked by the expression of dominant-nega-
tive mutant dynamin. G protein–coupled receptors interact with β-
arrestin, which acts as an adaptor for clathrin and AP-2 to promote 
internalization (Lefkowitz et al., 2006; Moore et al., 2007). The G 
protein–coupled receptors α2B-adrenergic receptor and the dop-
amine D2 receptor long isoform both require β-arrestin to internal-
ize (Kim et al., 2004; Wang et al., 2004), and their endocytosis is not 
blocked by expression of dynamin mutants (Schramm and Limbird, 
1999; Vickery and von Zastrow, 1999; Kim et al., 2004). We also in-
vestigated the caveolin and flotillin pathways as the most logical 
alternative candidates for regulating ATP7A endocytosis. Depletion 
of caveolin 1/2 or flotillin by RNAi appears to have no obvious effect 
on ATP7A cycling. It was reported that the stability of flotillin 1 and 
flotillin 2 proteins rely on each other, and the depletion of only one 
of them reduces the protein level of the other (Otto and Nichols, 
2011); targeting flotillin 1 alone is sufficient to reduce clathrin-inde-
pendent endocytosis (Glebov et al., 2006). These findings fit with 
our previous results showing that inhibitors of caveolae-mediated 
uptake do not affect ATP7A internalization (Cobbold et al., 2003). 
The results suggest that these pathways do not have a major in-
volvement in ATP7A trafficking.
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containing this motif mediates association of ATP7A with AP-2 and 
subsequently CME. Both clathrin and AP-2 depletion blocked inter-
nalization of a CD8 reporter containing the extreme 24 amino acids 
of the ATP7A carboxyl-terminus.
Other signals within the cytoplasmic domains of ATP7A may 
influence its internalization. ATP7A contains a PDZ binding motif 
(DTAL1500) at its extreme C-terminus (Greenough et al., 2004). 
Binding of G protein–coupled receptors to cellular PDZ-containing 
proteins recruits them to preexisting clathrin-coated pits but re-
duces their internalization rates (Puthenveedu and von Zastrow, 
2006). It has been suggested that PDZ interactions tether the re-
ceptors to cortical actin, which delays the scission of the vesicle 
and results in a distinct pool of slow-release primary endosomal 
vesicles, as opposed to the quick release seen with Tf receptor. 
Recently a similar observation was reported for the glutamate 
transporter (EAAC1/EAAT3) (D’Amico et al., 2010). The authors 
propose that the PDZ motif in EAAC1 regulates transporter endo-
cytosis by delaying its internalization through an AP-2–mediated 
pathway. Future studies will be needed to determine whether the 
PDZ binding domain of ATP7A influences its residence time on the 
cell surface.
ATP7A uses an AP-1 pathway to return to the TGN
AP-1 has been localized to clathrin-associated tubular structures 
in the TGN (Hinners and Tooze, 2003), and there is evidence that 
AP-2 is the clathrin adaptor required for ATP7A 
internalization from the PM
In cells depleted of AP-2, high copper levels stimulate ATP7A to 
traffic to the PM, but copper washout fails to trigger ATP7A’s return 
to the TGN. Thus it is clear that when ATP7A reaches the PM, AP-2 
is required for efficient internalization. Unlike the phenotype ob-
served for clathrin depletion, we do not observe an obvious block of 
ATP7A at the PM in AP-2 depleted cells under low-copper condi-
tions. We expected that if constitutive trafficking of ATP7A was a 
cycle between TGN and PM, then depleting AP-2 would show an 
ATP7A phenotype similar to clathrin knockdown. Given that the PM 
block of ATP7A was only observed after copper treatment, it sug-
gests that, under low-copper basal conditions, ATP7A constitutively 
cycles mostly between the TGN and an intracellular location. The 
most likely reason ATP7A can be observed to accumulate strongly 
at the PM in clathrin-depleted cells is that clathrin knockdown affects 
not only internalization from the PM but also intracellular trafficking 
back to the TGN. Therefore ATP7A in vesicles, unable to return to 
the TGN, may be targeted to the PM and eventually accumulate 
there.
The AP-2 adaptor protein complex plays a role in the internaliza-
tion of proteins such as HIV-Nef (Chaudhuri et al., 2007) through 
interactions with [D/E]XXXL[L/I] motifs. ATP7A contains a critical 
dileucine internalization signal within the sequence DKHSLL. Our 
results indicate that the region of the ATP7A carboxyl-terminus 
FIGURE 8: Expression of the Rab22aQ64L mutant inhibits ATP7A trafficking. HeLa cells transiently transfected with 
myc-tagged, constitutively active Rab22aQ64L were treated with CuCl2, fixed, and colabeled for ATP7A (green) and 
anti-myc to detect the Rab22a mutant (a), EEA1 (b), or golgin-97 (c) (all red). Cells expressing Rab22aQ64L (d) were 
treated with copper, followed by washout, and colabeled for ATP7A (green) and myc tag (red). Nuclei are labeled with 
DAPI (blue). Scale bar, 10 μm.
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ing endosomes (Magadan et al., 2006), endosome to TGN 
transport of the cation-independent mannose 6-phosphate re-
ceptor and cholera toxin (Mesa et al., 2005), and the sorting of 
nerve growth factor/pTrkA receptor into signaling endosomes 
(Wang et al., 2011). Our findings now suggest a new role for 
Rab22a in regulating the anterograde exit of ATP7A from the 
TGN to the PM.
In this study we clarify the importance of several regulators in 
the trafficking of ATP7A by identifying clathrin and the clathrin 
adaptors AP180, AP-2, and AP-1 and defining a novel role for 
Rab22a in the exit of ATP7A from the TGN. The results of this study 
are summarized in Table 1. We postulate that ATP7A traffics 
through the pathways shown in Figure 9. ATP7A constitutively cy-
cles between the TGN and early endosome and/or small sub-PM 
vesicles, and trafficking out of the TGN into either of these desti-
nations requires functional Rab22a. Elevated levels of copper di-
rect ATP7A to the PM, and when copper levels are reduced, ATP7A 
requires clathrin and AP-2 for efficient endocytosis. In addition, 
AP-1 is required for the delivery of ATP7A to the TGN, and lack of 
functional AP-1 appears to arrest ATP7A in small vesicles. Addi-
tional regulators are likely to further modulate each step of this 
pathway and remain to be characterized.
MATERIALS AND METHODS
Antibodies and plasmids
Monoclonal antibodies against golgin-97 (CDF4) and transferrin re-
ceptor (H68.4) were from Invitrogen (Carlsbad, CA), actin (ACTN05 
[C4]) from Abcam (Cambridge, MA), adaptin γ (110/3) and myc 
(9E10) from Sigma-Aldrich (St. Louis, MO), myc (9B11) from Cell 
Signaling Technology (Beverly, MA), and ATP7A (clone 34), caveolin 
1, caveolin 2, flotillin 1, p230, and AP-2 μ2 from BD Biosciences 
(San Diego, CA); CD8 (OKT8) was produced from a mouse hybri-
doma cell line obtained from the American Type Culture Collection 
(Manassas, VA).
Polyclonal antibodies against EEA1 (C45B10) and clathrin heavy 
chain (P1663) were from Cell Signaling Technology; GM130 has 
been described (Nelson et al., 1998); ATP7A (Steveson et al., 2003) 
was a kind gift from Betty Eipper (University of Connecticut Health 
Center, Farmington, CT). All other antibodies were from BD 
Biosciences.
CD8 constructs containing the ATP7A C-terminus have been 
described previously (Francis et al., 1999; Cobbold et al., 2003). 
The plasmid for overexpression of the mutant protein Rab11aS25N 
(a kind gift from Richard Pagano, Mayo Clinic College of Medicine, 
Rochester, MN; Choudhury et al., 2002) was modified to incorpo-
rate a single green fluorescent protein (GFP) tag at the N-termi-
nus (details provided on request) and checked by sequencing. 
Further Rab mutant constructs were generous gifts from the fol-
lowing: GFP-tagged Rab11bS25N and Rab11bQ70L, Beate Schlierf 
(Universität Erlangen-Nürnberg, Erlangen, Germany; Schlierf 
et al., 2000); myc-tagged Rab22aS19N and Rab22aQ64L, Vesa 
Olkkonen (National Institute for Health and Welfare, Helsinki, 
Finland; Kauppi et al., 2002); and myc-tagged AP180-C, Harvey 
McMahon (Laboratory of Molecular Biology, Cambridge Univer-
sity, Cambridge, United Kingdom; Ford et al., 2001). Plasmids 
were transfected into HeLa cells 12 h before experiments using 
ExGen 500 (Fermentas, Glen Burnie, MD) according to the manu-
facturer’s instructions.
Confocal laser scanning microscopy
HeLa cells were cultured and immunofluorescence was performed as 
previously described (Holloway et al., 2007). Images were captured 
AP-1 functions in the endosome-to-TGN retrograde pathway (Meyer 
et al., 2000). Our data indicate that the constitutive and copper-
induced trafficking of ATP7A back to the TGN involves an AP-1–
mediated pathway.
ATP7A has been shown to traffic to melanosomes in a biogen-
esis of lysosome-related organelles complex-1 (BLOC-1)–regu-
lated process (Setty et al., 2008). Hypopigmentation is observed 
in BLOC-1–deficient cells (Setty et al., 2007), and ATP7A most 
likely moves to the melanosome to supply the melanin biosyn-
thetic cuproenzymes with copper at their site of function. The role 
of AP-1 in the transport of ATP7A to the melanosome has not 
been characterized. However, AP-1 has been implicated in the 
trafficking of other melanosome cargo along microtubules through 
interaction with the kinesin motor KIF13A (Delevoye et al., 2009). 
The authors speculate that BLOC-1 may cooperate with AP-1 in 
the delivery of melanosome cargo. This is supported by the 
observation that knockdown of AP-1 in a zebrafish model sensi-
tized melanocytes to hypopigmentation in low-copper conditions 
(Ishizaki et al., 2010).
We observed a dependence on AP-1 for TGN localization of 
ATP7A under basal copper levels and for trafficking from the PM 
to the TGN after copper load and washout. AP-1 depletion does 
not appear to disrupt the TGN but, instead, selectively prevents 
the return of ATP7A to this compartment. In AP-1–depleted cells, 
ATP7A appears dispersed, and we hypothesize that it is predomi-
nantly found in small vesicles. This has not been directly observed, 
possibly because of the resolution limits of the light microscope. 
AP-1–mediated coating events are regulated by active forms of 
ARF, and we showed previously that inactivating cellular ARF dis-
rupts the steady-state localization of ATP7A and inhibits its traf-
ficking (Holloway et al., 2007). Our AP-1 depletion data agree 
with our previous report and suggest that AP-1 is essential in the 
pathway used by ATP7A to return to the TGN.
Rab22a is involved in anterograde ATP7A traffic 
from the TGN
Our data suggest that Rab22 might regulate the trafficking of ATP7A 
at the TGN. In cells expressing the constitutively active mutant Ra-
b22aQ64L, ATP7A can be observed in puncta in which ATP7A re-
mains even after copper treatment or after copper treatment fol-
lowed by washout. This compartment overlaps only partially with 
the TGN-resident golgin-97 and after copper treatment is indepen-
dent of golgin-97, suggesting that ATP7A is able to access a region 
of the TGN separate from golgin-97 or that Rab22aQ64L arrests 
ATP7A trafficking in a post-TGN compartment. However, Rab22aQ64L 
clearly prevents the copper-regulated exit of ATP7A and its inclusion 
into anterograde intermediates that deliver this membrane protein 
to the PM.
Fragmentation of the Golgi was reported in Rab22aQ64L-ex-
pressing cells (Kauppi et al., 2002). Rab22a might regulate traffick-
ing between Golgi and early endosomes, as Rab22a binds to EEA1. 
EEA1 has been shown to interact with syntaxin-6 (Simonsen et al., 
1999), a soluble N-ethylmaleimide–sensitive factor attachment pro-
tein receptor involved in transport events at the TGN (Mallard et al., 
2002; Nakamura et al., 2005). However, in our studies Rab22aQ64L 
did not alter the EEA1-containing endosomes, and ATP7A re-
mained distinct from the early endosomal compartments.
Rab22a has also been implicated in the clathrin-independent 
recycling of proteins: the major histocompatibility complexes 
MHCI and CD1a (Weigert et al., 2004; Barral et al., 2008) both 
use a Rab22a route for membrane protein recycling. Rab22a has 
also been associated with facilitating the exit of cargo from sort-
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set to Airy  = 1, with each fl uorochrome channel adjusted to the same 
z -slice optical thickness of  ∼ 0.8 μm. Non–pixel-saturating conditions 
using low laser power were used. Postacquisition analyses were per-
formed with the Zeiss LSM-510 Image Browser software. Photoshop 
Elements 8 (Adobe, San Jose, CA) image-editing software was used 
for further image processing. 
 Fluorescence image quantifi cation 
 Line averaging of 2 was performed for each image. Photomultiplier 
gain was set to ensure that there was no saturation in any of the 
channels, and the same gain settings were maintained for each 
using a Zeiss LSM-510 META laser scanning confocal microscope 
with a 40×/1.3 numerical aperture (NA) or 63×/1.4 NA oil immersion 
objective (Carl Zeiss, Jena, Germany). 4 ′ ,6-Diamidino-2-phenylindole 
(DAPI) was excited using a 405-nm laser diode, and signal was col-
lected through a bandpass (BP) 420- to 480-nm fi lter. Alexa Fluor 488 
(or GFP) was excited with a 488-nm argon laser, and fl uorescence 
was collected through a BP 505- to 530-nm emission fi lter; Alexa 
Fluor 594/555 was excited with a 543-nm laser, and fl uorescence was 
collected through a BP 593- to 794-nm or BP 565–615 emission fi lter; 
and Alexa Fluor 633 was excited with a 633-nm laser, and emission 
was collected through a BP 655–710 nm. The confocal pinhole was 
 FIGURE 9:  Regulators of ATP7A traffi cking. Schematic representation of the proposed traffi cking routes taken by 
endogenous ATP7A, either constitutively (left) or induced by copper level changes (right). Routes are marked by arrows, 
and blocks imposed by RNAi, mutant constructs, or drug treatment are shown (see also  Table 1 ). Putative involvement 
of AP-2 in the constitutive pathway is shown as (?) (see the text). AP180-C shows a similar phenotype to clathrin 
knockdown and is not included in the scheme. Rab22a Q64L  expression causes disruption of the TGN, which is not 
illustrated. Copper-induced forward pathway is shown as a direct traffi cking step to the PM, although intermediary 
vesicles might be involved as in the constitutive route. V, vesicle. 











CD8-LL4 No copper Vesicles/
perinuclear
– – – PM PM – –
ATP7A No copper TGN  – TGN Diffuse TGN PM PM Puncta
 ↑ copper PM – PM PM PM PM PM Puncta
 ↑ copper/ 
washout
TGN PM TGN Diffuse PM PM PM Puncta
 –, not done. 
TABLE 1:  Summary of treatment effect on endogenous ATP7A (or CD8-LL4) subcellular localization. 
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image. Three separate coverslips were imaged for each condition, 
and each coverslip was imaged in two randomly selected areas. 
Each image comprised a 2 × 2 tiled area equating to ∼40 μm2 
(∼250–300 cells/image). This analysis was repeated for two separate 
experiments done on separate days. In experiments in which trans-
fected cells expressing CD8-LL4 were analyzed an additional chan-
nel was generated that had a higher gain setting so that this could 
be used subsequently in the image analysis to select only trans-
fected cells. Image analysis was performed in ImageJ (National 
Institutes of Health, Bethesda, MD) with a custom-written macro 
(details available on request), and analysis was performed in Excel 
2010 (Microsoft, Redmond, WA) and Prism 5 (GraphPad Software, 
La Jolla, CA).
Trafficking assay
HeLa cells were treated with 200 μM CuCl2 in culture medium for 2 h 
at 37ºC and for the final 30 min in the presence of 50 μg/ml cyclo-
heximide. For the copper washout, cells were treated with CuCl2 as 
previously described, washed once with culture medium, and incu-
bated with culture medium containing 50 μg/ml cycloheximide and 
200 μM copper chelating agent BCS for 4 h at 37ºC. The medium 
was replaced twice during the course of the washout. Addition of 
the protein synthesis inhibitor cycloheximide ensures that only inter-
nalized ATP7A is observed after the copper washout and not ATP7A 
synthesized during the time course of the experiment. Trafficking 
experiments using the cell-permeable dynamin-inhibiting drug 
Dynasore (Sigma-Aldrich) were carried out essentially as described 
(Kirchhausen et al., 2008), substituting fetal bovine serum (FBS) in 
the culture medium for 10% Nuserum (BD Biosciences) and omitting 
BCS during the washout. Fresh stock solution of Dynasore was used 
at a working concentration of 80 μM and included in the final 30 min 
of CuCl2 treatment and during washout. Medium was replaced 
three times during the washout period.
RNA interference
siRNA duplexes were purchased from either Ambion (Austin, TX) or 
Qiagen (Valencia, CA). Those targeting the mRNA of CLTC or the μ2 
subunit of the AP-2 adaptor complex (AP2M1) were previously 
described (Murphy et al., 2008; Levecque et al., 2009). For AP-1 
depletion, siRNA targeting the μ1 subunit (AP1M1) corresponding 
to the mRNA region GGUGUUUUCCGAGUACUUC was used. The 
following siRNA targeting regions were also used: GAGUUAGUG-
GAUUACUGC (cav1), GGAUUGAAUACUUGGACCC (cav2), and 
GGUUUACACUCGCCAUGGG (flot1).
HeLa cells were transfected with 10–20 nM duplex siRNA using 
HiPerfect transfection reagent (Qiagen) according to the manufac-
turer’s instructions. Cells were transfected with siRNA on day 1, fol-
lowed by a second transfection on day 2, 24 h apart. Cells were split 
on day 3 and seeded into fresh 24-well plates for Western blotting 
or into wells containing coverslips for immunofluorescence. Cells 
were lysed or processed for immunofluorescence on day 4, 72 h af-
ter the initial siRNA transfection. In negative controls, targeting 
siRNA was substituted for AllStars negative nontargeting siRNA 
(Qiagen). To monitor transferrin internalization cells were incubated 
with 50 μg/ml human Tf conjugated to Alexa Fluor 594/633 (Invitro-
gen) in the relevant media for 15 min at 37°C before washing, fixing, 
and processing. Protocols for Western blotting and quantification of 
band intensities are described elsewhere (Holloway et al., 2007).
Cell surface biotinylation assay
Confluent HeLa cells silenced for clathrin heavy chain or treated with 
nontargeting negative control siRNA were cultured in the presence 
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of 200 μM BCS or 200 μM CuCl2 for 2 h in 35-mm dishes. Cell surface 
biotinylation was carried out at 4°C. Cells were cooled on ice and 
washed twice with cold DPBS, followed by incubation with Sulfo-
NHS-SS-biotin (Pierce, Rockford, IL) at a concentration of 0.5 mg/ml 
in cold Dulbecco’s phosphate-buffered saline (DPBS). The reaction 
was quenched in cold 10 mM glycine/DPBS, followed by 2× washes 
in cold DPBS. Cells were lysed in 0.5 ml of cold lysis buffer (150 mM 
NaCl, 1% NP-40, 50 mM Tris, pH 7.8, with protease inhibitors [EDTA 
free; Roche, Indianapolis, IN]), and 0.4-ml volumes of postnuclear 
supernatant were incubated with NeutrAvidin beads (Pierce) over-
night at 4°C to pull out the cell surface proteins. Beads were washed 
3× with cold lysis buffer and cell surface proteins eluted (e1) by heat-
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